loader
Please Wait
Applying Filters...
Close
4

Metrochem Dapagliflozin Metrochem Dapagliflozin

X

Information, Expiry & Status of FDA Orange Book Patents covering Dapagliflozin

Client Email Product
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ASTRAZENECA AB (107)

filter

01 6515117 (15)

02 7456254 (2)

03 7851502 (2)

04 7919598 (13)

05 8221786 (4)

06 8329648 (6)

07 8361972 (8)

08 8431685 (2)

09 8461105 (2)

10 8501698 (15)

11 8628799 (6)

12 8685934 (7)

13 8716251 (8)

14 8721615 (2)

15 8906851 (2)

16 9238076 (2)

17 9616028 (9)

18 10973836 (1)

19 11826376 (1)

filter

01 Y (28)

02 Blank (79)

filter

01 Y (69)

02 Blank (38)

filter

01 2024-04-15 (2)

02 2025-04-13 (4)

03 2025-06-30 (2)

04 2025-07-13 (6)

05 2025-10-04 (15)

06 2026-08-18 (8)

07 2027-06-20 (15)

08 2028-03-21 (20)

09 2028-08-19 (2)

10 2029-12-16 (13)

11 2030-01-18 (2)

12 2030-05-26 (7)

13 2030-11-12 (9)

14 2039-07-18 (1)

15 2040-03-09 (1)

URL Supplier Web Content
8685934
2030-05-26
U-1522
202293
TREATMENT OF TYPE 2 DIABETES MELLITUS IN A PATIENT, WHEREIN GLYCEMIC CONTROL (HBA1C < 7.0%) IS NOT ACHIEVABLE USING ONE OR MORE OF INSULIN, METFORMIN,
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
6515117
Y
Y
2025-10-04
U-493
205649
TREATMENT OF TYPE 2 DIABETES MELLITUS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
6515117
Y
Y
2025-10-04
U-493
205649
TREATMENT OF TYPE 2 DIABETES MELLITUS
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8501698
Y
2027-06-20
U-493
205649
TREATMENT OF TYPE 2 DIABETES MELLITUS
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
6515117
Y
Y
2025-10-04
U-493
205649
TREATMENT OF TYPE 2 DIABETES MELLITUS
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8501698
Y
2027-06-20
U-493
205649
TREATMENT OF TYPE 2 DIABETES MELLITUS
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8685934
2030-05-26
U-1522
205649
TREATMENT OF TYPE 2 DIABETES MELLITUS IN A PATIENT, WHEREIN GLYCEMIC CONTROL (HBA1C < 7.0%) IS NOT ACHIEVABLE USING ONE OR MORE OF INSULIN, METFORMIN,
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8906851
2026-08-18
U-2139
202293
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9238076
Y
2024-04-15
U-2139
202293
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8329648
2026-08-18
U-2213
202293
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY